Weill Cornell Medicine, officially the Joan & Sanford I. Weill Medical College of Cornell University, is the biomedical research unit and medical school of Cornell University.

During the past decade, Weill Cornell Medical College conducted 650 clinical trials. In the 10-year time frame, 650 clinical trials started and 378 clinical trials were completed, i.e. on average, 58.2% percent of trials that started reached the finish line to date. In the past 5 years, 288 clinical trials started and 188 clinical trials were completed. i.e. 65.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Weill Cornell Medical College" #1 sponsor was "Weill Medical College of Cornell University" with 408 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 77 trials sponsored, "Alliance for Clinical Trials in Oncology" with 64 trials sponsored, "Gilead Sciences" with 31 trials sponsored and "Celgene" with 31 trials sponsored. Other sponsors include 690 different institutions and companies that sponsored additional 346 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Weill Cornell Medical College" #1 collaborator was "National Cancer Institute (NCI)" with 143 trials as a collaborator, "Weill Medical College of Cornell University" with 41 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 32 trials as a collaborator, "National Institutes of Health (NIH)" with 19 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 18 trials as a collaborator. Other collaborators include 915 different institutions and companies that were collaborators in the rest 470 trials.

According to Clinical.Site data, the most researched conditions in "Weill Cornell Medical College" are "HIV Infections" (95 trials), "Prostate Cancer" (50 trials), "Multiple Myeloma" (43 trials), "Lymphoma" (30 trials) and "Acute Myeloid Leukemia" (25 trials). Many other conditions were trialed in "Weill Cornell Medical College" in a lesser frequency.

Most popular intervention types in "Weill Cornell Medical College" are "Drug" (847 trials), "Other" (159 trials), "Biological" (132 trials), "Device" (104 trials) and "Procedure" (103 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (124 trials), "Dexamethasone" (25 trials), "cyclophosphamide" (23 trials), "Rituximab" (22 trials) and "Zidovudine" (21 trials). Other intervention names were less common.

The vast majority of trials in "Weill Cornell Medical College" are 1155 trials for "All" genders, 83 trials for "Male" genders and 62 trials for "Female" genders.

Currently, there are 388 active trials in "Weill Cornell Medical College". 8 are not yet recruiting, 212 are recruiting, 154 are Active, not recruiting, and 14 are Enrolling by invitation. In total, there were 681 completed trials in Weill Cornell Medical College, 4 suspended trials, and 163 terminated clinical trials to date.

Out of the total trials that were conducted in Weill Cornell Medical College, 220 "Phase 1" clinical trials were conducted, 442 "Phase 2" clinical trials and 261 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 66 trials, and there were also 209 trials that are defined as “Not Applicable".